PEDRO HENRIQUE XAVIER NABUCO DE ARAUJO
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/61 - Laboratório de Pesquisa em Cirurgia Torácica, Hospital das Clínicas, Faculdade de Medicina
LIM/61 - Laboratório de Pesquisa em Cirurgia Torácica, Hospital das Clínicas, Faculdade de Medicina
2 resultados
Resultados de Busca
Agora exibindo 1 - 2 de 2
bookPart 0 Citação(ões) na Scopus MANAGEMENT OF NON-SMALL CELL LUNG CANCER IN LATIN AMERICA(2020) CAPARICA, R.; GABRIELLI, F. C.; ARAUJO, P. H. N. De; TERRA, R. M.; LIM, F.; WAN, B. A.; ALBUQUERQUE, L. F. De; SILVA, M. F.Non-small cell lung cancer is the leading cause of cancer deaths globally and also in Latin America. Several treatment strategies are available, such as surgery and radiotherapy for early-stage disease, and chemotherapy, immunotherapy and targeted therapies for metastatic patients. The decision on which treatment is more appropriate for an individual patient depends on performance status, comorbidities, tumour staging, availability of resources, and risk of toxicities. A multidisciplinary approach involving medical oncologists, surgeons, radiation oncologists, respiratory medicine specialists and palliative care doctors is crucial for successful treatment of NSCLC. This chapter will discuss the main treatment strategies for NSCLC in Latin America, focusing on the limitations, singularities, and perspectives of NSCLC treatment in this region. © 2020 by Nova Science Publishers, Inc. All rights reserved.- Robotic thoracic surgery for non-small cell lung cancer: initial experience in Brazil(2020) TERRA, Ricardo Mingarini; BIBAS, Benoit Jacques; HADDAD, Rui; MILANEZ-DE-CAMPOS, Jose Ribas; NABUCO-DE-ARAUJO, Pedro Henrique Xavier; TEIXEIRA-LIMA, Carlos Eduardo; SANTOS, Felipe Braga dos; LAURICELLA, Leticia Leone; PEGO-FERNANDES, Paulo ManuelObjective: To describe the morbidity, mortality, and rate of complete resection associated with robotic surgery for the treatment of non-small cell lung cancer in Brazil, as well as to report the rates of overall survival and disease-free survival in patients so treated. Methods: This was a retrospective study of patients diagnosed with non-small cell lung carcinoma and undergoing resection by robotic surgery at one of six hospitals in Brazil between February of 2015 and July of 2018. Data were collected retrospectively from the electronic medical records. Results: A total of 154 patients were included. The mean age was 65 +/- 9.5 years (range, 30-85 years). The main histological diagnosis was adenocarcinoma, which was identified in 128 patients (81.5%), followed by epidermoid carcinoma, identified in 14 (9.0%). Lobectomy was performed in 133 patients (86.3%), and segmentectomy was performed in 21 (13.7%). The mean operative time was 209 +/- 80 min. Postoperative complications occurred in 32 patients (20.4%). The main complication was air leak, which occurred in 15 patients (9.5%). The median (interquartile range) values for hospital stay and drainage time were 4 days (3-6 days) and 2 days (2-4 days), respectively. There was one death in the immediate postoperative period (30-day mortality rate, 0.5%). The mean follow-up period was 326 +/- 274 days (range, 3-1,110 days). Complete resection was achieved in 97.4% of the cases. Overall mortality was 1.5% (3 deaths), and overall survival was 97.5%. Conclusions: Robotic pulmonary resection proved to be a safe treatment for lung cancer. Longer follow-up periods are required in order to assess long-term survival.